Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
420
-
Total 13F shares, excl. options
-
52,365,391
-
Shares change
-
-1,938,309
-
Total reported value, excl. options
-
$8,637,480,699
-
Value change
-
-$302,903,361
-
Put/Call ratio
-
42%
-
Number of buys
-
179
-
Number of sells
-
-195
-
Price
-
$165.05
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2020
467 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q4 2020.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 420 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52,365,391 shares
.
Largest 10 shareholders include BlackRock Inc. (6,395,173 shares), VANGUARD GROUP INC (4,877,893 shares), RENAISSANCE TECHNOLOGIES LLC (3,099,050 shares), FMR LLC (2,868,719 shares), LSV ASSET MANAGEMENT (2,269,527 shares), STATE STREET CORP (2,254,618 shares), JPMORGAN CHASE & CO (1,901,136 shares), AQR CAPITAL MANAGEMENT LLC (1,013,295 shares), Boston Partners (977,426 shares), and CITADEL ADVISORS LLC (950,051 shares).
This table shows the top 420 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.